Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items (2017 - 2022)

Historic Non-cash Items for Arcus Biosciences (RCUS) over the last 6 years, with Q4 2022 value amounting to $6.7 million.

  • Arcus Biosciences' Non-cash Items fell 9735.83% to $6.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $6.7 million, marking a year-over-year decrease of 9735.83%. This contributed to the annual value of $6.7 million for FY2022, which is 9735.83% down from last year.
  • As of Q4 2022, Arcus Biosciences' Non-cash Items stood at $6.7 million, which was down 9735.83% from $253.6 million recorded in Q4 2021.
  • Over the past 5 years, Arcus Biosciences' Non-cash Items peaked at $253.6 million during Q4 2021, and registered a low of $1.1 million during Q4 2019.
  • In the last 5 years, Arcus Biosciences' Non-cash Items had a median value of $11.0 million in 2018 and averaged $78.9 million.
  • In the last 5 years, Arcus Biosciences' Non-cash Items surged by 1057245.96% in 2020 and then crashed by 9735.83% in 2022.
  • Over the past 5 years, Arcus Biosciences' Non-cash Items (Quarter) stood at $11.0 million in 2018, then plummeted by 89.59% to $1.1 million in 2019, then soared by 10572.46% to $122.2 million in 2020, then surged by 107.49% to $253.6 million in 2021, then plummeted by 97.36% to $6.7 million in 2022.
  • Its Non-cash Items stands at $6.7 million for Q4 2022, versus $253.6 million for Q4 2021 and $122.2 million for Q4 2020.